₹473.00
−1.88%NSE close, 16 Nov 2026
+170.97%
Bafna Pharmaceuticals is a small cap company, listed on NSE under the symbol BAFNAPH. At ₹473.00 a share, the market values the whole company at ₹1,119 crore.
In FY26, it reported sales of ₹151 crore and a net profit of ₹11 crore, an operating margin of 10.6%. Over the last three years, sales grew 9.3% a year and net profit fell 0.7% a year.
The market values the company at 97.1 times its profit over the last twelve months and 10.84 times its book value; its return on equity is 11.2% and its borrowings are 0.36 times its equity.
Promoters hold 75.00% of the shares. Foreign institutions hold 9.34%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has risen 184.5%, and it is 5.7% below its 52-week high.
₹ crore. Standalone figures: the company files no consolidated results.
| Line | Dec 2023 S | Mar 2024 S | Jun 2024 S | Sep 2024 S | Dec 2024 S | Mar 2025 S | Jun 2025 S | Sep 2025 S |
|---|
The Outcome of the Board Meeting held on 11/11/2026 along with the Unaudited Financial Results and Limited Review Report issued by the Statutory Auditors, for the Quarter and Half Year ended September 30, 2026.
Voting Results of the 31st Annual General Meeting of the Company held on September 11, 2026 along with the Scrutinizer Report.
Proceedings of the 31st Annual General Meeting of the Company held on September 11, 2026
Notice of 31st Annual General Meeting of the Company to be held on September 11, 2026 along with the Annual Report for F.Y 2025-2026
| Dec 2025 S |
|---|
| Mar 2026 S |
|---|
| Jun 2026 S |
|---|
| Sep 2026 S |
|---|
| Sales | 28.4 | 41.4 | 33.3 | 40.3 | 33.2 | 39.1 | 34.6 | 35.5 | 38.3 | 42.2 | 26.6 | 47.7 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 30.5 | 38.5 | 32.1 | 36.5 | 30.1 | 36.0 | 29.5 | 31.2 | 35.2 | 38.7 | 25.7 | 39.1 |
| Operating profit | −2.1 | 2.9 | 1.2 | 3.8 | 3.1 | 3.1 | 5.1 | 4.3 | 3.1 | 3.6 | 0.9 | 8.6 |
| Operating margin | -7.3% | 7.0% | 3.6% | 9.4% | 9.2% | 8.0% | 14.6% | 12.1% | 8.0% | 8.4% | 3.3% | 18.0% |
| Other income | 1.0 | 0.5 | 0.5 | 1.0 | 0.2 | 1.0 | 0.6 | 1.2 | 1.2 | 1.8 | 1.9 | 1.1 |
| Interest | 0.6 | 0.7 | 0.7 | 0.6 | 0.6 | 0.8 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 1.0 |
| Depreciation | 1.3 | 1.3 | 1.4 | 1.6 | 1.7 | 0.2 | 1.4 | 1.5 | 1.6 | 1.7 | 1.8 | 1.9 |
| Profit before tax | −2.9 | 1.5 | −0.7 | 2.6 | 1.0 | 1.3 | 3.4 | 3.1 | 1.8 | 2.6 | 0.1 | 6.9 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0.1 | 0 | 0 |
| Net profit | −2.9 | 1.5 | −0.7 | 2.6 | 1.0 | 1.3 | 3.4 | 3.1 | 1.8 | 2.8 | 0.1 | 6.9 |
| EPS (₹) | -1.24 | 0.62 | -0.31 | 1.11 | 0.40 | 0.55 | 1.43 | 1.32 | 0.78 | 1.16 | 0.03 | 2.89 |
₹ crore, financial years to March.
| Line | FY20 | FY21 S | FY22 S | FY23 S | FY24 S | FY25 S | FY26 S |
|---|---|---|---|---|---|---|---|
| Sales | 42.5 | 71.2 | 85.1 | 115 | 152 | 146 | 151 |
| Expenses | 41.3 | 60.9 | 73.7 | 100.0 | 141 | 135 | 135 |
| Operating profit | 1.2 | 10.3 | 11.5 | 15.4 | 11.1 | 11.2 | 16.0 |
| Operating margin | 2.9% | 14.5% | 13.5% | 13.3% | 7.3% | 7.7% | 10.6% |
| Other income | 0.3 | 0.8 | 2.1 | 3.6 | 3.5 | 2.7 | 4.8 |
| Interest | 0.1 | 0.7 | 0.8 | 2.0 | 2.3 | 2.7 | 3.7 |
| Depreciation | 3.3 | 4.5 | 5.5 | 5.3 | 5.0 | 4.9 | 6.1 |
| Profit before tax | −24.4 | 5.8 | 5.2 | 11.6 | 7.4 | 4.2 | 11.0 |
| Tax | 0 | 0 | 0 | 0.3 | 0 | 0 | −0.1 |
| Net profit | −24.7 | 5.8 | 5.2 | 11.3 | 7.4 | 4.2 | 11.1 |
| EPS (₹) | -15.52 | 2.46 | 4.34 | 4.85 | 3.11 | 1.76 | 4.69 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 6.5 | 22.1 | 15.4 | 10.1 |
| From investing | −4.5 | −21.2 | −22.4 | −8.9 |
| From financing | −3.6 | 1.1 | 5.6 | −1.9 |
| Spent on fixed assets | −7.5 | −21.9 | −24.9 | −8.9 |
| Free cash flow | −1.0 | 0.3 | −9.5 | 1.1 |
Margins, returns, debt, tax and cash.
| Line | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net margin | -58.2% | 8.2% | 6.0% | 9.8% | 4.8% | 2.8% | 7.4% |
| Operating margin | 2.9% | 14.5% | 13.5% | 13.3% | 7.3% | 7.7% | 10.6% |
| Return on equity | – | – | – | 15.4% | 9.1% | 4.9% | 11.5% |
| Return on capital employed | – | – | – | 14.2% | 9.2% | 6.1% | 11.0% |
| Return on assets | – | – | – | 8.7% | 5.0% | 2.7% | 6.3% |
| Debt to equity | – | – | – | 0.31 | 0.30 | 0.33 | 0.39 |
| Interest coverage | -243.40 | 8.90 | 7.50 | 6.70 | 4.20 | 2.50 | 4.00 |
| Debt to assets | – | – | – | 0.18 | 0.17 | 0.18 | 0.21 |
| Current ratio | – | – | – | 1.88 | 1.75 | 1.63 | 1.57 |
| Quick ratio | – | – | – | 1.40 | 1.20 | 1.09 | 1.06 |
| Cash ratio | – | – | – | 0.17 | 0.03 | 0.07 | 0.04 |
| Asset turnover | – | – | – | 0.89 | 1.03 | 0.95 | 0.86 |
| Fixed asset turnover | – | – | – | 2.87 | 3.79 | 2.48 | 1.84 |
| Inventory turnover | – | – | – | – | 2.90 | 2.90 | 2.80 |
| Receivables turnover | – | – | – | 2.80 | 3.40 | 3.60 | 3.40 |
| Gross margin | – | – | – | – | 43.1% | 44.5% | 45.6% |
| Cash from operations to profit | – | – | 127.0% | – | – | 533.0% | 138.0% |
| Effective tax rate | – | 0.0% | 0.0% | 2.4% | 0.0% | 0.0% | – |
Intimation for Book Closure & Cut off Date
Intimation for 31st Annual General Meeting of the Company to be held on September 11, 2026
Outcome of Board Meeting held on August 11, 2026.
The outcome of the Board Meeting held on 11/08/2026 along with the unaudited financial results for the quarter ended June 30, 2026.
A copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026